These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8703706)

  • 1. Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous?
    Kees-Folts D
    Pediatr Nephrol; 1996 Apr; 10(2):180. PubMed ID: 8703706
    [No Abstract]   [Full Text] [Related]  

  • 2. The changing face of childhood nephrotic syndrome.
    Chesney R
    Kidney Int; 2004 Sep; 66(3):1294-302. PubMed ID: 15327442
    [No Abstract]   [Full Text] [Related]  

  • 3. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake.
    Rodrigo R; Bravo I; Pino M
    Nutr Rev; 1996 Nov; 54(11 Pt 1):337-47. PubMed ID: 9110562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S; Surapaitoolkorn W; Tancharoen W; Pattaragarn A; Sumboonnanonda A
    Pediatr Int; 2012 Dec; 54(6):793-7. PubMed ID: 22621380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitor does not reduce proteinuria in an infant with congenital nephrotic syndrome of the Finnish type.
    Birnbacher R; Förster E; Aufricht C
    Pediatr Nephrol; 1995 Jun; 9(3):400. PubMed ID: 7632545
    [No Abstract]   [Full Text] [Related]  

  • 7. The nephrotic syndrome.
    Orth SR; Ritz E
    N Engl J Med; 1998 Apr; 338(17):1202-11. PubMed ID: 9554862
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of lisinopril on proteinuria in children with nephrotic syndrome in Ilorin, Nigeria.
    Adedoyin OT; Ologe MO; Anigilaje EA; Adeniyi A
    Pediatr Nephrol; 2003 Jul; 18(7):727-8. PubMed ID: 12734747
    [No Abstract]   [Full Text] [Related]  

  • 9. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
    Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP
    Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M; Colazo A; Vallejo G; Zotta E
    Nefrologia (Engl Ed); 2021; 41(3):304-310. PubMed ID: 36166246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor.
    McGregor D; Bailey RR
    Nephron; 1997; 76(3):270-5. PubMed ID: 9226226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
    Praga M; Hernández E; Montoyo C; Andrés A; Ruilope LM; Rodicio JL
    Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal modulation of proteinuria in the nephrotic syndrome.
    Hutchison FN
    Am J Nephrol; 1993; 13(5):337-46. PubMed ID: 8116686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV
    Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome.
    Garini G; Mazzi A; Allegri L; Buzio C; Borghetti A
    Miner Electrolyte Metab; 1996; 22(1-3):123-7. PubMed ID: 8676802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult nephrotic syndrome: non-specific strategies for treatment.
    Charlesworth JA; Gracey DM; Pussell BA
    Nephrology (Carlton); 2008 Feb; 13(1):45-50. PubMed ID: 18199102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic edema--pathogenesis and treatment.
    Palmer BF
    Am J Med Sci; 1993 Jul; 306(1):53-67. PubMed ID: 8328511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J; Radhakrishnan J
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
    Trachtman H; Del Pizzo R; Valderrama E; Gauthier B
    Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrotic syndromes].
    Peraldi MN
    Rev Infirm; 1988 Nov; 38(17):29-31. PubMed ID: 3217662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.